CLASS III Drug recall · Reported 20 Jun 2012 · FDA Enforcement Report

DermaZinc Spray, 0.25% zinc pyritione, topical recalled

Quadrant Chemical is recalling DermaZinc Spray, 0.25% zinc pyritione, topical, distributed in Maine. The recall was initiated on 20 Mar 2012 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 022110-01
Quantity recalled4800 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1380-2012
FDA event ID
61518
Recalling firm
Quadrant Chemical, Garland, TX
Classification
Class III
Status
Terminated
Recall initiated
20 Mar 2012
FDA classified
14 Jun 2012
Reported
20 Jun 2012
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

20 Mar 2012Recall initiated by company
14 Jun 2012Classified by FDA+86 days
20 Jun 2012Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

DermaZinc Spray, 0.25% zinc pyritione, topical OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070

Where it was distributed

Maine

Maine

Questions about this recall

Why was it recalled?

Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.

Which lots are affected?

Lot 022110-01

Where was it sold?

Maine

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.